Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness

Insufficient control of chronic breathlessness may induce excessive use of fentanyl nasal spray in COPD patients. Prescription of fentanyl nasal spray for breathlessness should only be done as part of palliative treatment and requires close follow-up. http://bit.ly/2YdOjJ1

Detalles Bibliográficos
Autores principales: Janssen, Daisy J.A., van den Beuken-van Everdingen, Marieke H.J., Verberkt, Cornelia A., Creemers, Jacques P.H.M., Wouters, Emiel F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876137/
https://www.ncbi.nlm.nih.gov/pubmed/31777575
http://dx.doi.org/10.1183/20734735.0183-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876137/
https://www.ncbi.nlm.nih.gov/pubmed/31777575
http://dx.doi.org/10.1183/20734735.0183-2019

Ejemplares similares